Evidence map›Paper›PMID 25681667›Full record

ArticleAnaerobe2015

Variation in germination of Clostridium difficile clinical isolates correlates to disease severity.

Paul E Carlson, Alyssa M Kaiser, Sarah A McColm, Jessica M Bauer, Vincent B Young, David M Aronoff, Philip C Hanna

Abstract read
In one paragraph

Article in Anaerobe, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Clostridioides difficile Sporulation.Advances in experimental medicine and biology · 2024
    Review
  2. Review
  3. Article
  4. Microbiology (Reading, England) · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Treatment issues in recurrentFEMS microbes · 2020
    Review
  10. Article
  11. Clinics in colon and rectal surgery · 2020
    Review
  12. Article
  13. Frontiers in pediatrics · 2020
    Article
  14. Article
  15. Review
  16. Article
  17. The Journal of biological chemistry · 2018
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paul E CarlsonDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA.
Alyssa M KaiserDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA.
Sarah A McColmDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA.
Jessica M BauerDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA.
Vincent B YoungDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Internal Medicine, Division of Infectious Diseases, University of Michigan, Ann Arbor, MI 48109, USA.
David M AronoffDivision of Infectious Diseases, Department of Medicine, Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Philip C HannaDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: pchanna@umich.edu.

Funding

MICHIGAN INSTITUTE FOR CLINICAL AND HEALTH RESEARCH (MICHR) (UL1): (BPCA)UL1RR024986 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$51.2M
Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
The Interplay Between Host Immunity and Clostridium difficile PathogenesisU19AI090871 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YOUNG, VINCENT B · 2010 to 2014
$7.5M
NCATS NIH HHS UL1 TR000433NCRR NIH HHS UL1 RR024986NCRR NIH HHS UL1RR024986NIAID NIH HHS U19 AI09087NIAID NIH HHS U19 AI090871
6 · The paper itself

Abstract

Over the past two decades, Clostridium difficile infections have been increasing in both number and severity throughout the world. As with other spore forming bacteria, germination is a vital step in the life cycle of this pathogen. Studies have examined differences in sporulation and toxin production among a number of C. difficile clinical isolates; however, few have examined differences in germination and the relationship between this phenotype and disease severity. Here, over 100 C. difficile isolates from the University of Michigan Health System were examined for overall germination in response to various combinations of known germinants (taurocholate) and co-germinants (glycine and histidine). Significant variation was observed among isolates under all conditions tested. Isolates representing ribotype 014-020, which was the most frequently isolated ribotype at our hospital, exhibited increased germination in the presence of taurocholate and glycine when compared to isolates representing other ribotypes. Interestingly, isolates that caused severe disease exhibited significantly lower germination in response to minimal germination conditions (taurocholate only), indicating increased control over germination in these isolates. These data provide a broad picture of C. difficile isolate germination and indicate a role for precise control of germination in disease severity.

Indexed as

Spores, BacterialClostridioides difficileEnterocolitis, PseudomembranousHumansSeverity of Illness IndexClostridium difficileGerminationNAP1/027RibotypeSpore

Identifiers

PMID25681667
PMCPMC4467518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.